Why do patients with congestive heart failure tolerate the initiation of β-blocker therapy?

Howard L. Haber, Christopher L. Simek, Lawrence W. Gimple, James D. Bergin, Komathi Subbiah, Ananda R. Jayaweera, Eric R. Powers, Marc D. Feldman

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Why do patients with congestive heart failure tolerate the initiation of β-blocker therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences